• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALUNG TECHNOLOGIES, INC. HEMOLUNG RAS; EXTRACORPOREAL SYSTEM FOR CARBON DIOXIDE REMOVAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALUNG TECHNOLOGIES, INC. HEMOLUNG RAS; EXTRACORPOREAL SYSTEM FOR CARBON DIOXIDE REMOVAL Back to Search Results
Model Number HL-CR4-01-000-RECERT
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Anemia (1706)
Event Date 03/08/2021
Event Type  Injury  
Event Description
Alung technologies, inc.Received a report of a patient experiencing anemia during hemolung therapy.Two units of blood was given to the patient.Hemolung therapy was not discontinued as a result of this event.
 
Manufacturer Narrative
This patient information was not provided.Alung technologies, inc.Manufactures the hemolung ras and catheter.The incident occurred in pittsburgh, pennsylvania.Through review of the expanded access form, it was reported that the patient experienced anemia during hemolung therapy.Two units of blood were given to the patient and therapy was not discontinued as a result of this issue.The data log from therapy has been retrieved and reviewed by both clinical and software engineering staff.No abnormalities were noted within the co2 removal and blood flow graphs.Therapy was provided as intended.No capa was opened because of this event.Anemia is a known possible complication that can occur during extracorporeal therapy.The treating physician was able to fully realize their clinical goals and significant benefit of therapy was realized.Examination of the controller data log shows that therapy was provided as intended.Alung technologies, inc.Will continue to monitor any issues as they are reported.This mdr is being filed in response to a retrospective view of all alung technologies, inc.Complaints, which identified that the reporting decision for this complaint was not correct.This mdr is being filed retrospectively to correct the error in the reporting decision.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HEMOLUNG RAS
Type of Device
EXTRACORPOREAL SYSTEM FOR CARBON DIOXIDE REMOVAL
Manufacturer (Section D)
ALUNG TECHNOLOGIES, INC.
2500 jane st
suite 1
pittsburgh PA 15203
Manufacturer Contact
ryan coyle
2500 jane st
suite 1
pittsburgh, PA 15203
MDR Report Key16211946
MDR Text Key307765235
Report Number3009763347-2023-00096
Device Sequence Number1
Product Code QOH
UDI-Device Identifier00850046004346
UDI-Public(01)00850046004346(17)180827
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
DEN210006
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 01/19/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/19/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberHL-CR4-01-000-RECERT
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received05/03/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured08/27/2018
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Life Threatening;
Patient Age65 YR
Patient SexFemale
-
-